Systemic lupus erythematosus (SLE) is a chronic autoimmune condition with unpredictable
course, intermingled with flares and periods of remission. Although the prognosis of the …

Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disorder with
severe morbidity and mortality and diverse systemic involvement. Disease onset occurs …

Systemic lupus erythematosus (SLE) is a debilitating autoimmune disease that can involve
multi-organs. B cells play a central role in the immunopathogenesis via antibody-dependent …

The application of life-saving transplantation is severely limited by the shortage of organs,
and histoincompatibility. To increase transplant rates in sensitized patients, new protocols …

Significant progress has been made in the development of therapies for systemic lupus
erythematosus (SLE). These include agents which target interferons, cytokines, T …

Jaccoud's arthropathy (JA) is a condition characterized clinically by 'reversible'joint
deformities along with an absence of articular erosions on a plain radiograph. The main …

Systemic lupus erythematous (SLE) is a chronic multisystem disease with significant
associated morbidity and mortality. A deeper understanding of the pathogenesis of SLE has …

Introduction: The approval of belimumab and other advances in the field have narrowed the
window for off-label use of biologicals in systemic lupus erythematosus (SLE). For …

In recent years, significant progress has been made in the use of monoclonal antibodies in
the treatment of systemic lupus erythematosus (SLE). Advances in our understanding of the …